NASDAQ
PD-Rx Pharmaceuticals, Inc. (PDRX) has a eps (diluted) of $-0.17 as of Monday, June 30, 2025. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.